TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
The American Geriatrics Society has published a case-based framework for clinicians prescribing obesity medications, including incretin therapies, to older adults. It emphasizes assessing function, nutrition and cognition before treatment and pairing medication with measures such as resistance training and adequate protein intake.
The American Geriatrics Society (AGS) has released a case-based framework to help clinicians prescribe obesity medications safely for older adults, a group that has been underrepresented in clinical trials. The paper, published in the Journal of the American Geriatrics Society, calls for assessment of function, nutrition and cognition before treatment, alongside attention to age-related risks such as frailty and loss of lean muscle.
Developed by the AGS Healthy Aging Special Interest Group, the paper applies the society’s Geriatrics 5Ms Framework to incretin-based obesity therapies, including GLP-1 medications. The five areas are Mind, Mobility, Medications, Multicomplexity and Matters Most, a structure intended to help clinicians consider a patient’s health and priorities beyond weight alone.
The authors say pretreatment evaluation should include functional status, nutritional adequacy and cognitive impairment. They also point to potential concerns for older patients, including sarcopenia and frailty, loss of lean muscle, malnutrition and dehydration. The report presents these as factors clinicians should weigh when planning care; it does not establish that every older adult taking these medications will experience those problems.
The framework recommends pairing medication with supportive measures, including resistance training and adequate dietary protein. Depending on a patient’s needs, care may involve a team such as a registered dietitian, physical therapist, fitness trainer and behavioral health professional. The paper is by Elias M. Wisdom and colleagues and was published in 2026 under DOI 10.1111/jgs.70769.
Balancing Weight Treatment With Function
The framework addresses a practical challenge in prescribing: weight management is not the only health consideration for an older adult. Changes in muscle, mobility, hydration and nutrition may affect how a treatment fits an individual’s health and daily life. The paper’s approach encourages clinicians to assess those issues and the patient’s priorities as part of prescribing, rather than focusing on medication choice alone.
The guidance also matters because the authors describe older adults as underrepresented in clinical trials of these medications. That limits how confidently findings from broader study populations can be applied to every older patient. A structured, individualized assessment offers clinicians a way to identify relevant risks and supportive care needs, although the framework itself does not resolve gaps in trial evidence.
Products Worth Considering
BowFlex Results Series SelectTech Adjustable Dumbbells, Pair
Fitbit Sense Advanced Smartwatch – Sage Grey/Silver (One Size, S & L Bands Included)
Levoit Core 600S-P Smart Air Purifier for Large Rooms
As an affiliate, we earn on qualifying purchases.
Applying the Geriatrics 5Ms
The report focuses on incretin therapy, a category that includes GLP-1 medications acting through gut-derived hormonal pathways. The source describes these drugs as having potential benefits for weight management, glycemic control and other health conditions, while emphasizing the need to consider older adults’ age-related health factors.
Rather than offering a one-size-fits-all prescribing rule, the paper organizes guidance around clinical cases and the 5Ms. The framework asks clinicians to consider cognition and mental well-being, mobility, other medications, complex health needs, and what matters most to the individual. Its recommendations concern clinical assessment and care planning; the source does not provide a new drug approval, dosing protocol or trial result.
“The framework applies the Geriatrics 5Ms Framework—Mind, Mobility, Medications, Multicomplexity, and Matters Most—to incretin therapy in older adults.”
— Elias M. Wisdom and colleagues, authors of the paper
Evidence Gaps in Older Patients
The source material does not report new clinical-trial results, patient outcomes or a formal evaluation of how well the framework changes prescribing or health. It also gives no specific estimates of the frequency or severity of muscle loss, dehydration, malnutrition or other concerns. The extent to which these risks vary among older adults, and how they may differ by medication or individual health profile, is not established in the report summary.
It is also unclear from the available information whether the AGS will issue additional implementation tools or update the framework as more evidence becomes available. The paper is guidance for clinicians, not a claim that a particular medication is appropriate for all older adults.
How Clinicians May Use the Guidance
The immediate next step is for clinicians to apply the framework when discussing obesity medication options with older patients, using assessment of function, nutrition, cognition and personal priorities to inform care. The authors’ suggested co-interventions, including resistance training and adequate protein intake, can be considered alongside medication where appropriate to a patient’s circumstances.
Further research involving older adults would help clarify benefits and risks in this population and inform future prescribing guidance. The source material does not announce a study timeline or a planned AGS update, so any additional publication or implementation milestones remain unknown.
Key Questions
What did the American Geriatrics Society publish?
The AGS published a case-based framework for clinicians prescribing obesity medications, including incretin therapies, to older adults. It applies the Geriatrics 5Ms approach to treatment decisions.
What should clinicians assess before prescribing?
The paper recommends reviewing functional status, nutritional adequacy and cognitive impairment, while considering factors such as frailty, sarcopenia, muscle loss, malnutrition and dehydration.
What supportive measures does the framework recommend?
It recommends pairing medication with measures such as resistance training and adequate dietary protein. Some patients may benefit from coordinated support involving nutrition, physical therapy, fitness or behavioral health professionals.
Does the framework say obesity medications are suitable for every older adult?
No. It offers a way to guide individualized clinical decisions and does not recommend a medication for every older adult. Treatment suitability depends on a patient’s health, risks and priorities.
Why does the paper emphasize caution in older adults?
The authors note that older adults are underrepresented in clinical trials and may have age-related considerations, including frailty and nutritional or muscle concerns. The report does not quantify those risks for individual patients.
Source: medicalxpress.com
